Symbol | Exchange | Currency |
|---|
Investing.com – U.S. stocks were mixed after the close on Thursday, as gains in the Technology, Healthcare and Consumer Services sectors led shares higher while losses in the Oil &...
Investing.com – U.S. stocks were mixed after the close on Monday, as gains in the Healthcare, Technology and Consumer Services sectors led shares higher while losses in the Oil &...
Investing.com – U.S. stocks were higher after the close on Thursday, as gains in the Oil & Gas, Telecoms and Utilities sectors led shares higher. At the close in NYSE, the Dow...
Shares of Cellect Biotechnology Ltd. (NASDAQ:APOP) surged 70.4% after the company received "Intention to Grant" patents from European and Israeli patent offices.Shares of Apache...
Cellect Biotechnology Ltd. (NASDAQ:APOP) exploded on some really big news, jumping 2.69, or 38%, to 9.81, on 3.8 million shares traded on Thursday. The last time it exploded was...
Cellect Biotechnology Ltd (NASDAQ:APOP) On Thursday before the market opened shares of Cellect Biotechnology ($APOP) skyrocketed over 50% after they announced a successful stem...
As of October 28, 2021, Cellect Biotechnology Ltd. was acquired by Quoin Pharmaceuticals, Inc., in a reverse merger transaction. Cellect Biotechnology Ltd., a biotechnology company, engages in developing ApoGraft, a technology platform that functionally selects stem cells to enhance the safety of regenerative medicine and stem cell therapies in Israel. The company develops ApoTainer, a kit for hematopoietic stem cell transplantation procedures. It has collaborations with the denovoMATRIX group of the Technische Universität Dresden to conduct examinations into the tentative synergy between ApoGraft and denovoMAtrix technology for the purpose of evaluating collaborative development of products for regenerative medicine; Cell2in Inc. to conduct scientific evaluations combining ApoGraft with Cell2in’s identification technology FreSHtracer, which monitors stem cell quality by utilizing a fluorescent dye to characterize their oxidative stress state; and XNK therapeutics to focus on the development of cell-based therapeutics from NK cells. The company was formerly known as Cellect Biomed Ltd. and changed its name to Cellect Biotechnology Ltd. in July 2016. Cellect Biotechnology Ltd. was incorporated in 1986 and is headquartered in Kfar Saba, Israel.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Sell | Strong Sell | Strong Sell | Sell | Strong Sell |
| Technical Indicators | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Sell |
| Summary | Strong Sell | Strong Sell | Strong Sell | Strong Sell | Strong Sell |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 195.28 | 197.33 | 194.42 | +1.40 | +0.72% | 109.50M | NASDAQ | |||
| 162.36 | 162.47 | 161.27 | +1.59 | +0.99% | 46.76M | NASDAQ | |||
| 61.85 | 62.09 | 61.66 | -0.01 | -0.02% | 8.35M | NYSE | |||
| 207.84 | 208.09 | 202.82 | +2.49 | +1.21% | 22.53M | NASDAQ | |||
| 100.89 | 101.15 | 99.78 | -0.50 | -0.49% | 32.74M | NASDAQ | |||
| 284.05 | 284.46 | 281.48 | +3.54 | +1.26% | 24.97M | NASDAQ | |||
| 40.38 | 40.49 | 40.25 | +0.13 | +0.32% | 12.49M | NYSE | |||
| 97.88 | 99.53 | 97.25 | +1.79 | +1.86% | 58.34M | NASDAQ | |||
| 102.00 | 103.04 | 101.01 | +1.75 | +1.75% | 51.96M | NASDAQ | |||
| 162.67 | 164.50 | 162.41 | +0.54 | +0.33% | 1.16M | NASDAQ | |||
| 273.83 | 274.99 | 271.02 | +3.99 | +1.48% | 35.62M | NASDAQ | |||
| 8.15 | 8.38 | 8.05 | -0.07 | -0.85% | 20.57M | NYSE | |||
| 101.32 | 101.61 | 100.29 | -0.58 | -0.57% | 24.17M | NASDAQ | |||
| 46.51 | 47.32 | 46.02 | -0.19 | -0.41% | 12.10M | NYSE | |||
| 10.27 | 10.275 | 10.27 | -0.010 | -0.10% | 66.38K | NYSE |